MoneyWorks4Me

Glaxosmithkline Pharmaceuticals informs about analyst meet

11 Feb 2025 Evaluate
Pursuant to Regulation 30 read with para A of Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Glaxosmithkline Pharmaceuticals has informed that an group analyst meeting is scheduled on 14th February 2025 via Digital.

The above information is a part of company’s filings submitted to BSE.


Peers
Company Name CMP
Sun Pharma. Inds. 1846.30
Dr. Reddys Labs. 1147.45
Cipla 1359.20
Lupin 2050.80
Zydus Lifesciences 1108.25
View more..